DANONE (BSN.DE) Forecast, Price Target & Analyst Ratings
FRA:BSN • FR0000120644
69.34 EUR
-0.84 (-1.2%)
Last: Mar 9, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for DANONE (BSN.DE).
Forecast Snapshot
Consensus Price Target
€80.77
+ 16.48% Upside
Next Earnings Forecast
Release DateApr 22, 2026
PeriodQ2 / 2026
EPS Estimate€1.95
Revenue Estimate14.262B
ChartMill Buy Consensus
75.15%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€80.77
Upside
+ 16.48%
From current price of €69.34 to mean target of €80.77, Based on 33 analyst forecasts
Low
€66.55
Median
€79.43
High
€99.58
Price Target Revisions
1 Month
0.13%
3 Months
-0.20%
Price Target Summary
33 Wall Street analysts provided a forecast for the next 12 months for BSN.DE. The average price target is 80.77 EUR. This implies a price increase of 16.48% is expected in the next year compared to the current price of 69.34.
The average price target has been revised downward by 0.2% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
75.15%
BSN.DE was analyzed by 33 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about BSN.DE.
In the previous month the buy percentage consensus was at a similar level.
BSN.DE was analyzed by 33 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-08-03 | Jefferies | Initiate | |
| 2021-07-30 | Barclays | Initiate | |
| 2021-06-30 | JPMorgan Chase | Initiate | Buy |
| 2021-06-29 | Morgan Stanley | Initiate | Neutral |
| 2021-06-24 | JPMorgan Chase | Initiate | Neutral |
| 2021-06-17 | Goldman Sachs | Initiate | Sell |
| 2021-06-09 | RBC Capital | Initiate | Sell |
| 2021-05-26 | Berenberg Bank | Initiate | Sell |
| 2021-05-13 | Goldman Sachs | Initiate | Sell |
| 2021-04-21 | JPMorgan Chase | Initiate | Neutral |
| 2021-04-21 | Jefferies | Initiate | Buy |
| 2021-03-30 | Kepler Cheuvreux | Initiate | Buy |
| 2021-03-25 | Credit Suisse | Initiate | Neutral |
| 2021-03-22 | Jefferies | Initiate | Buy |
| 2021-03-15 | RBC Capital | Initiate | Neutral |
| 2021-03-02 | Jefferies | Initiate | Buy |
| 2021-03-01 | Societe Generale | Initiate | Sell |
| 2021-02-22 | Berenberg Bank | Initiate | Neutral |
| 2021-02-22 | Deutsche Bank | Initiate | Neutral |
| 2021-02-12 | Sanford Bernstein | Initiate | Sell |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 22, 2026
PeriodQ2 / 2026
EPS Estimate€1.95
Revenue Estimate14.262B
Revenue Q2Q3.82%
EPS Q2Q2.19%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
BSN.DE is expected to report earnings on 4/22/2026. The consensus EPS estimate for the next earnings is 1.95 EUR and the consensus revenue estimate is 14.26B EUR.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 27.619B -0.15% | 27.376B -0.88% | 27.283B -0.34% | 28.895B 5.91% | 30.025B 3.91% | 31.244B 4.06% | 33.24B 6.39% | 34.663B 4.28% | 33.797B -2.50% | 34.816B 3.02% | 35.841B 2.94% | |
| EBITDA YoY % growth | 5.102B -2.74% | 4.728B -7.33% | 5.023B 6.24% | 5.109B 1.71% | 5.396B 5.62% | 5.66B 4.89% | 6.135B 8.39% | 6.451B 5.15% | 6.072B -5.88% | 6.257B 3.05% | 6.412B 2.48% | |
| EBIT YoY % growth | 3.491B 3.19% | 3.56B 1.98% | 3.668B 3.03% | 3.943B 7.50% | 4.194B 6.37% | 4.375B 4.32% | 4.777B 9.19% | 5.041B 5.53% | 4.823B -4.32% | 4.973B 3.11% | 5.128B 3.12% | |
| Operating Margin | 12.64% | 13.00% | 13.44% | 13.65% | 13.97% | 14.00% | 14.37% | 14.54% | 14.27% | 14.28% | 14.31% | |
| EPS YoY % growth | 3.54 3.21% | 3.63 2.54% | 3.80 4.68% | 4.09 7.51% | 4.40 7.75% | 4.77 8.29% | 5.13 7.60% | 5.53 7.89% | N/A | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 26 | Q4 / 26 | |
|---|---|---|
| EPS Q2Q % growth | 1.95 2.19% | 2.11 11.72% |
| Revenue Q2Q % growth | 14.262B 3.82% | 14.432B 6.54% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | 1.914B 5.69% | N/A |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
7.85%
EPS Next 5 Year
7.81%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
3.54%
Revenue Next 5 Year
4.25%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
14.85%
EBIT Next 5 Year
11.54%
DANONE / BSN.DE Forecast FAQ
What is the price target for BSN stock?
33 analysts have analysed BSN.DE and the average price target is 80.77 EUR. This implies a price increase of 16.48% is expected in the next year compared to the current price of 69.34.
What is the next earnings date for BSN stock?
DANONE (BSN.DE) will report earnings on 2026-04-22.
What are the consensus estimates for DANONE (BSN.DE) next earnings?
The consensus EPS estimate for the next earnings of DANONE (BSN.DE) is 1.95 EUR and the consensus revenue estimate is 14.26B EUR.
What is the consensus rating for BSN stock?
The consensus rating for DANONE (BSN.DE) is 75.1515 / 100 . This indicates that analysts generally have a positive outlook on the stock.